Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
Exposure of infected CV-1 cells to specific type I and type II topoisomerase poisons caused strong protein association with distinct subsets of simian virus 40 (SV40) DNA replication intermediates. On the basis of the known specificity and mechanisms of action of these drugs, the proteins involved are assumed to be the respective topoisomerases. Camptothecin, a topoisomerase I poison, caused strong protein association with form II (relaxed circular) and form III (linear) viral genomes and replication intermediates having broken DNA replication forks but not with form I (superhelical) viral DNA or normal late replication intermediates which were present. In contrast, type II topoisomerase poisons caused completely replicated forms and late viral replication forms to be tightly bound to protein--some to a greater extent than others. Different type II topoisomerase inhibitors caused distinctive patterns of protein association with the replication intermediates present. Both intercalating and nonintercalating type II topoisomerase poisons caused a small amount of form I (superhelical) SV40 DNA to be protein-associated in vivo. The protein complex with form I viral DNA was entirely drug-dependent and strong, but apparently noncovalent. The protein associated with form I DNA may represent a drug-stabilized "topological complex" between type II topoisomerase and SV40 DNA.
Shin
C G
CG
Department of Radiology, Ohio State University, Columbus 43210-1214.
Snapka
R M
RM
D000818:Animals; D002166:Camptothecin / Q000494:pharmacology; D002522:Chlorocebus aethiops; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000235:genetics*; D003852:Deoxyribonucleoproteins / Q000648:ultrastructure*; D004611:Ellipticines / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D011370:Proflavine / Q000494:pharmacology; D013539:Simian virus 40 / Q000235:genetics*; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
D004279:DNA, Viral; D003852:Deoxyribonucleoproteins; D004611:Ellipticines; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; C034192:ellipticine; D005047:Etoposide; D011370:Proflavine; D002166:Camptothecin